Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Comprehensive Hearing Loss + mtDNA MNG Laboratories (Medical Neurogenetics, LLC.) United States | 218 | 300 |
|
F13A1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics, part of Exact Sciences United States | 346 | 160 |
|
Factor XIII (13) Gene Sequencing (F13A1 and F13B) (2 Day STAT TAT) Machaon Diagnostics United States | 2 | 2 |
|
Versiti Diagnostic Laboratories Versiti, Inc United States | 3 | 9 |
|
Congenital Factor XIII deficiency via the F13A1 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 78 | 79 |
|
Molecular Haemostasis & Thrombosis Synnovis Analytics LLP - Guy's and St. Thomas' NHS Foundation Trust United Kingdom | 2 | 2 |
|
Coagulation Factor Deficiency Panel PreventionGenetics, part of Exact Sciences United States | 21 | 20 |
|
Clotting factor deficiency panel. 16-gene NGS panel. Genologica Medica Spain | 29 | 16 |
|
Bleeding disorder / coagulopathy panel. NGS panel of 62 genes. Genologica Medica Spain | 96 | 62 |
|
Duzen Laboratories Duzen BBAGUAS Turkey | 1 | 1 |
|
Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders Germany | 1 | 1 |
|
Genetiks Genetic Diagnosis Center Genetic Diseases Evaluation Center Turkey | 1 | 1 |
|
Comprehensive Bleeding Disorder Panel Versiti Diagnostic Laboratories Versiti, Inc United States | 80 | 50 |
|
F13A1 (Factor XIII-A) - Genetic Analysis Versiti Diagnostic Laboratories Versiti, Inc United States | 1 | 1 |
|
MNG Laboratories (Medical Neurogenetics, LLC.) United States | 2 | 2 |
|
Versiti Diagnostic Laboratories Versiti, Inc United States | 25 | 20 |
|
Fulgent Genetics United States | 46 | 18 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.